TRIPS and access to medicines : pharmaceutical patents and the experience of Brazil
- Full Title:
- TRIPS and access to medicines : pharmaceutical patents and the experience of Brazil
- Curzel, Renata.
- Statement of Responsibility:
- Renata Curzel
- 352 p.
- TRIPS and Access to Medicines is a timely topic examining the Brazilian health and innovation policy, given the challenges of the COVID-19 pandemic, and contributing...
Summary:TRIPS and Access to Medicines is a timely topic examining the Brazilian health and innovation policy, given the challenges of the COVID-19 pandemic, and contributing to the discussion on the balance of patent rights and the right of access to medicines. Although ideally a patent system for pharmaceuticals should serve to incentivize research into the development of new medicines, the COVID-19 pandemic has exposed the equal importance access to drug and its affordability. This book, by focusing on the Brazilian rule which makes the grant of pharmaceutical patents dependent on the prior consent of the National Health Surveillance Agency (ANVISA), shows how the Brazilian model could be an example for other countries to follow in dealing with challenges of patent protection and the right to healthcare.
Based on an empirical study in which the author examined 147 reports issued by ANVISA as a basis for its decisions, the book deals with central questions concerning the interface of regulation and innovation in the patent system such as the following: compatibility between ANVISA’s prior consent mechanism and the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; how “evergreening” and “trivial patents” undermine public health and access to medicines; ways of correcting abuses of patent rights and controlling quality of patents; and discourse on health as a human right. In its commitment to harmonizing patent rights and the right to access of affordable medicines, Brazil’s patent system for pharmaceuticals stands out as a workable response to the basic problem of access to medicines in the developing world.
- • List of Abbreviations • List of Tables • Acknowledgments • CHAPTER 1: Introduction • CHAPTER 2: The Case of Patents and Drugs • CHAPTER...
Contents:• List of Abbreviations • List of Tables • Acknowledgments • CHAPTER 1: Introduction • CHAPTER 2: The Case of Patents and Drugs • CHAPTER 3: The Case of Patents and Drugs in Brazil • CHAPTER 4: Integrating Pharmacological Superior Expertise in the Patent Examination for Public Health Policies Interests • CHAPTER 5: Lessons for the Future • Bibliography • Table of Cases • Personal Interviews • List of Cited ANVISA’s Reports on Prior Consent Within Patent Proceedings at the INPI • Index
- Publisher & Date:
- AH Alphen aan den Rijn : Kluwer Law International, 2021.
- Date of Publication:
- Kluwer Law International
- D 14.1.3
- 9789403528823 (hbk)
In the Library
|Call Number||Location||Availability||Description||Loan Type|
|D 14.1.3 Cur 2021||General collection||On Shelf||-||For regular loan|
In the Library
D 14.1.3 Cur 2021